Calcium phosphate granules for use as a 5-Fluorouracil delivery system

abstract

The possibility of tailoring apatite granules as a controlled release system for the drug model 5-Fluorouracil (5FU) has been examined. Apatite granules (SDG) were obtained by spray drying suspensions of hydroxyapatite (HAP) nanoparticles previously precipitated from citrate solutions [M.A. Martins, C. Santos, M.E.V. Costa, M.M. Almeida, Preparation of porous hydroxyapatite particles to be used as drug delivery systems, Advanced Materials Forum 11 (455) (2004) 353-357]. SDG had donut shape and very high specific surface area (150 m(2)/g) indicative of high porosity. SDG were. poorly crystalline HAP but turned into biphasic granules (HSDG) with crystalline tricalcium phosphate and HAP after annealing at 800 degrees C, while reducing their surface area down to similar to 6 m(2)/g. SDG and HSDG were soaked in a 5FU solution at pH 5.2 and room temperature during several days and then transferred to a phosphate buffered solution (PBS) at pH 7.4 and 37 degrees C, for releasing 5FU. The comparison between the 5FU adsorbing and releasing behaviours exhibited by SDG and HSDG shows that engineering the granules characteristics, i.e. specific surface area, surface chemical composition, porosity and crystal phase composition allows the 5FU release profile to be controlled. (C) 2008 Elsevier Ltd and Techna Group S.r.l. All rights reserved.

keywords

BETA-TRICALCIUM PHOSPHATE; HYDROXYAPATITE PARTICLES; DRUG-DELIVERY; MICROSPHERES; CELLS; NANOPARTICLES; BIOCERAMICS; BONE; FABRICATION; COMPOSITE

subject category

Materials Science

authors

Santos, C; Martins, MA; Franke, RP; Almeida, MM; Costa, MEV

our authors

acknowledgements

This work was supported in part by the European Project G5RD-CT2000-00282 Tissue Reactor.

Share this project:

Related Publications

We use cookies for marketing activities and to offer you a better experience. By clicking “Accept Cookies” you agree with our cookie policy. Read about how we use cookies by clicking "Privacy and Cookie Policy".